Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Andrea, Urwin"'
Autor:
Kyuhan Lee, Shakthi Gunasinghe, Alyson Chapman, Lynne A. Findlow, Jody Hyland, Sheetal Ohol, Andrea Urwin, Martin K. Rutter, Jonathan Schofield, Hood Thabit, Lalantha Leelarathna
Publikováno v:
Biosensors, Vol 11, Iss 11, p 457 (2021)
Flash glucose monitoring (FGM) and real-time continuous glucose monitoring (RT-CGM) are increasingly used in clinical practice, with improvements in HbA1c and time in range (TIR) reported in clinical studies. We aimed to evaluate the impact of FGM an
Externí odkaz:
https://doaj.org/article/2ef86de035a34cff94019bb89f5ec5ae
Autor:
A. O’Carroll-Lolait, J. Schofield, I. Doughty, Hood Thabit, Lalantha Leelarathna, Andrea Urwin
Publikováno v:
O’carroll-lolait, A, Urwin, A, Doughty, I, Schofield, J, Thabit, H & Leelarathna, L 2020, ' Trends in HbA1c and other biochemical outcomes of individuals with newly diagnosed type 1 diabetes ', Irish Journal of Medical Science . https://doi.org/10.1007/s11845-020-02434-w
Irish Journal of Medical Science
Irish Journal of Medical Science
BackgroundThere is limited data on glycaemic control and cardiovascular risk factor management in newly diagnosed individuals with type 1 diabetes in the first 2 years.MethodsRetrospective, single centre study from the North West of England, newly di
Autor:
Bilal Bashir, Panchami Elisaus, Viktoria Chatzimavridou Grigoriadou, Andrea Urwin, Alyson Chapman, Sheetal Ohol, Lynne Ann Findlow, Jody Foster, Rachel Harwood, Catherine Fullwood, Jonathan Schofield, Martin K. Rutter, Lalantha Leelarathna, Hood Thabit
Publikováno v:
Diabetic medicine : a journal of the British Diabetic AssociationREFERENCES. 39(5)
Autor:
Alyson Chapman, Lalantha Leelarathna, Sheetal Ohol, Jody Hyland, Kyuhan Lee, Jonathan Schofield, Martin K. Rutter, Shakthi Gunasinghe, Andrea Urwin, Lynne A Findlow, Hood Thabit
Publikováno v:
Lee, K, Gunasinghe, S, Chapman, A, Findlow, L A, Hyland, J, Ohol, S, Urwin, A, Rutter, M K, Schofield, J, Thabit, H & Leelarathna, L 2021, ' Real-World Outcomes of Glucose Sensor Use in Type 1 Diabetes—Findings from a Large UK Centre ', Biosensors, vol. 11, no. 11, pp. 457 . https://doi.org/10.3390/bios11110457
Biosensors
Volume 11
Issue 11
Biosensors, Vol 11, Iss 457, p 457 (2021)
Biosensors
Volume 11
Issue 11
Biosensors, Vol 11, Iss 457, p 457 (2021)
Flash glucose monitoring (FGM) and real-time continuous glucose monitoring (RT-CGM) are increasingly used in clinical practice, with improvements in HbA1c and time in range (TIR) reported in clinical studies. We aimed to evaluate the impact of FGM an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::194a09b545ba40a8661db8c4593076c2
https://www.mdpi.com/2079-6374/11/11/457
https://www.mdpi.com/2079-6374/11/11/457
Autor:
Womba Musumadi Mubita, Joshi Navis Prabhu, Shazli Azmi, Hood Thabit, Lalantha Leelarathna, Ian M. Doughty, Ik Hur Teoh, Andrea Urwin
Publikováno v:
J Diabetes Sci Technol
Autor:
Martin K. Rutter, Jonathan Schofield, Lalantha Leelarathna, Womba Musumadi Mubita, Hood Thabit, Andrea Urwin, Joshi Prabhu Navis
Publikováno v:
Acta Diabetologica
Aims People with type 1 diabetes (T1D) face the daily task of implementing self-management strategies to achieve their glycaemic goals. The UK COVID-19 lockdown has had an impact on day-to-day behaviour, which may affect diabetes self-management and
Autor:
Joshi Navis Prabhu, Hood Thabit, I. Doughty, Catherine Fullwood, Shazli Azmi, Andrea Urwin, Lalantha Leelarathna, Womba Musumadi Mubita
Publikováno v:
Thabit, H, Prabhu, J N, Mubita, W, Fullwood, C, Azmi, S, Urwin, A, Doughty, I & Leelarathna, L 2020, ' Use of Factory-Calibrated Real-time Continuous Glucose Monitoring Improves Time in Target and HbA1c in a Multiethnic Cohort of Adolescents and Young Adults With Type 1 Diabetes : The MILLENNIALS Study ', Diabetes Care, vol. 43, no. 10, pp. 2537-2543 . https://doi.org/10.2337/dc20-0736
OBJECTIVE International type 1 diabetes registries have shown that HbA1c levels are highest in young people with type 1 diabetes; however, improving their glycemic control remains a challenge. We propose that use of the factory-calibrated Dexcom G6 C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b53f0beb0cc691e1034640385489f19
https://www.research.manchester.ac.uk/portal/en/publications/use-of-factorycalibrated-realtime-continuous-glucose-monitoring-improves-time-in-target-and-hba1c-in-a-multiethnic-cohort-of-adolescents-and-young-adults-with-type-1-diabetes(043ae0d7-71ac-4c1d-b90a-cfb6aecf94cf).html
https://www.research.manchester.ac.uk/portal/en/publications/use-of-factorycalibrated-realtime-continuous-glucose-monitoring-improves-time-in-target-and-hba1c-in-a-multiethnic-cohort-of-adolescents-and-young-adults-with-type-1-diabetes(043ae0d7-71ac-4c1d-b90a-cfb6aecf94cf).html
Autor:
Lalantha Leelarathna, Ian Doughty, Andrea Urwin, Shazli Azmi, Catherine Fullwood, Womba Mubita, Joshi Navis Prabhu, Hood Thabit
Objective: International type 1 diabetes registries have shown that HbA1c levels are highest in young people with type 1 diabetes, however improving their glycaemic control remains a challenge. We propose that use of factory-calibrated Dexcom G6 CGM
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9d2cee131ea4da7bb6dbfa2c21d8086
https://doi.org/10.2337/figshare.12616208
https://doi.org/10.2337/figshare.12616208
Autor:
Shazli Azmi, Womba Musumadi Mubita, Hood Thabit, Lalantha Leelarathna, Ian M. Doughty, Joshi Paul-Prabhu, Catherine Fullwood, Andrea Urwin
Publikováno v:
Diabetes. 69
Improving glycaemic control in young people with type 1 diabetes (T1D) remains challenging. No study has specifically evaluated efficacy and usability of DexCom G6 CGM in this cohort. Adolescents and young adults with T1D (age 16 to 25 years old) on
Autor:
Hood, Thabit, Joshi Navis, Prabhu, Womba, Mubita, Catherine, Fullwood, Shazli, Azmi, Andrea, Urwin, Ian, Doughty, Lalantha, Leelarathna
Publikováno v:
Diabetes care. 43(10)
International type 1 diabetes registries have shown that HbAWe conducted a randomized crossover trial in young people with type 1 diabetes (16-24 years old) comparing the Dexcom G6 CGM system and self-monitoring of blood glucose (SMBG). Participants